Tower Research Capital (TRC)’s Cadrenal Therapeutics CVKD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.64K | Buy |
+136
| New | +$1.64K | ﹤0.01% | 4769 |
|
2025
Q1 | – | Sell |
-368
| Closed | -$5.33K | – | 5287 |
|
2024
Q4 | $5.33K | Buy |
+368
| New | +$5.33K | ﹤0.01% | 4307 |
|
2024
Q3 | – | Sell |
-644
| Closed | -$4.54K | – | 5743 |
|
2024
Q2 | $4.54K | Buy |
644
+9
| +1% | +$63 | ﹤0.01% | 4770 |
|
2024
Q1 | $5.81K | Buy |
635
+69
| +12% | +$631 | ﹤0.01% | 4485 |
|
2023
Q4 | $6.29K | Buy |
566
+1
| +0.2% | +$11 | ﹤0.01% | 4762 |
|
2023
Q3 | $5.76K | Buy |
565
+547
| +3,039% | +$5.58K | ﹤0.01% | 4691 |
|
2023
Q2 | $408 | Sell |
18
-22
| -55% | -$499 | ﹤0.01% | 5630 |
|
2023
Q1 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 5515 |
|